Insiders · RADX

RADX insider transactions

Radiopharm Theranostics Limited (RADX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

RADX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Radiopharm Theranostics Limited, latest first. Follow anyone to get their next filing.

• Dimitris VoliotisChief Medical Officer, since March 2026
• Paul HopperDirector, since March 2026
• Aaron James LauritaChief Financial Officer, since March 2026
• Noel DonnellyDirector, since March 2026
• Ian Lawrence TurnerDirector, since March 2026
• Riccardo CanevariManaging Director and CEO, since March 2026
• Hester Denise LarkinDirector, since March 2026

Recent Form 3, 4, and 5 filings for RADX

• 12d
  SEC Form 4 filed by Radiopharm Theranostics Limited

  4 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 186d
  SEC Form 3 filed by new insider Voliotis Dimitris

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 187d
  New insider Hopper Paul claimed ownership of 147,721,428 units of Ordinary Shares (SEC Form 3)

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 192d
  New insider Laurita Aaron James claimed ownership of 26,357 units of Ordinary Shares (SEC Form 3)

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 221d
  SEC Form 3 filed by new insider Donnelly Noel

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 222d
  SEC Form 3 filed by new insider Turner Ian Lawrence

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 223d
  SEC Form 3 filed by new insider Canevari Riccardo

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 223d
  SEC Form 3 filed by new insider Larkin Hester Denise

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)
• 236d
  SEC Form 3 filed by Radiopharm Theranostics Limited

  3 - Radiopharm Theranostics Ltd (0001949257) (Issuer)